14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of MACK
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Evaluation of Merrimack Pharmaceuticals stock downgraded after the last trading session.
(Updated on May 03, 2024)

Buy or Hold candidate since Apr 26, 2024 Gain 1.83% PDF

The Merrimack Pharmaceuticals stock price fell by -0.200% on the last day (Friday, 3rd May 2024) from $15.03 to $15.00. During the last trading day the stock fluctuated 0.233% from a day low at $15.00 to a day high of $15.03. The price has risen in 5 of the last 10 days and is up by 1.9% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -19 thousand shares and in total, 187 thousand shares were bought and sold for approximately $2.81 million.

The stock lies in the upper part of a weak rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $15.04 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 4.81% during the next 3 months and, with a 90% probability hold a price between $14.39 and $15.76 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

MACK Signals & Forecast

The Merrimack Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $14.85 and $14.74. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, May 02, 2024, and so far it has fallen -0.200%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements. The stock had a Golden Star Signal on Friday, April 19, 2024 for the short-term and also have Golden Star Signal for the medium-term dated Friday, September 22, 2023.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Buy
Special Signal Notification

Golden Star

The stock had a Golden Star Signal on Friday, April 19, 2024 for the short-term and also have Golden Star Signal for the medium-term dated Friday, September 22, 2023.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.
Buy
Special Signal Notification

Golden Star 12 Months

The stock had a Golden Star Signal on Friday, April 19, 2024 for the short-term and also have Golden Star Signal for the medium-term dated Friday, September 22, 2023.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Merrimack Pharmaceuticals stock

Merrimack Pharmaceuticals finds support from accumulated volume at $14.70 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.0350 between high and low, or 0.233%. For the last week the stock has had daily average volatility of 0.356%.

The Merrimack Pharmaceuticals stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: $14.50 (-3.32%) (This stock has low daily movements and this gives low risk. The RSI14 is 88 and this increases the risk substantially. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (MACK) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Merrimack Pharmaceuticals to open at $15.01, and during the day (based on 14 day Average True Range), to move between $14.92 and $15.08, which gives a possible trading interval of +/-$0.0796 (+/-0.53%) up or down from last closing price. If Merrimack Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 1.06% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $15.03 (0.20%) than the support at $14.70 (2.00%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Merrimack Pharmaceuticals stock A Buy?

Merrimack Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: 0.365 Hold/Accumulate Downgraded

Predicted Opening Price for Merrimack Pharmaceuticals of Monday, May 6, 2024

Fair opening price May 6, 2024 Current price
$15.01 ( 0.0556%) $15.00

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for MACK

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 15.04 0.289 %
R2 15.03 0.200 %
R1 15.02 0.145 %
Current price: 15.00
Support S1 14.99 -0.0336 %
S2 14.99 -0.0886 %
S3 14.97 -0.178 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 15.03 0.200 %
Current price 15.00
Support S1 14.70 -2.00%
S2 14.68 -2.13%
S3 14.67 -2.20%

MACK Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Dec 03, 2019 Dec 13, 2019 Dec 23, 2019 $0.500 14.20%
2 Jul 25, 2019 Sep 06, 2019 Sep 05, 2019 $1.50 27.17%
3 Apr 05, 2017 May 30, 2017 May 26, 2017 $8.30 31.97%

FAQ

What is the symbol for Merrimack Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Merrimack Pharmaceuticals is MACK and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Merrimack Pharmaceuticals Stock?
Merrimack Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy Merrimack Pharmaceuticals Stock?
Merrimack Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Merrimack Pharmaceuticals Stock.

What's the current price of Merrimack Pharmaceuticals Stock?
As of the end of day on the May 03, 2024, the price of an Merrimack Pharmaceuticals (MACK) share was $15.00.

What is the 52-week high and low for Merrimack Pharmaceuticals Stock?
The 52-week high for Merrimack Pharmaceuticals Stock is $5.49 and the 52-week low is $0.360.

What is the market capitalization of Merrimack Pharmaceuticals Stock?
As of the May 03, 2024, the market capitalization of Merrimack Pharmaceuticals is 217.977M.

When is the next earnings date for Merrimack Pharmaceuticals?
The upcoming earnings date for Merrimack Pharmaceuticals is Aug 01, 2024.
Click to get the best stock tips daily for free!

About Merrimack Pharmaceuticals

Merrimack Pharmaceuticals Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.... MACK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT